In vivo blockage of nitric oxide with aminoguanidine inhibits immunosuppression induced by an attenuated strain of Salmonella typhimurium, potentiates Salmonella infection, and inhibits macrophage and polymorphonuclear leukocyte influx into the spleen

Infection and Immunity

Volumn 67, Issue 2, 1999, Pages 891-898

  MacFarlane, Amanda Shearer ^b   Schwacha, Martin G ^a,b   Eisenstein, Toby K ^b  

^a BROWN UNIVERSITY   (United States)

^b TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGUANIDINE; N(G) METHYLARGININE; NITRIC OXIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; FEMALE; HOST RESISTANCE; MACROPHAGE; MOUSE; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; SALMONELLA TYPHIMURIUM; SALMONELLOSIS; SPLEEN CELL; TYPHOID FEVER;

EID: 0032934731     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/iai.67.2.891-898.1999     Document Type: Article

References (56)

1. Adams, L. B., S. G. Franzblau, Z. Vavrin, J. B. Hibbs, Jr., and J. L. Krahenbuhl. 1991. L-Arginine-dependent macrophage effector functions inhibit metabolic activity of Mycobaaerium leprae. J. Immunol. 147:1642-1646.
2. Al-Ramadi, B. K., M. A. Brodkin, D. M. Mosser, and T. K. Eisenstein. 1991. Immunosuppression induced by attenuated Salmonella: evidence for mediation by macrophage precursors. J. Immunol. 146:2737-2746.
3. Al-Ramadi, B. K., J. M. Greene, J. J. Meissler, Jr., and T. K. Eisenstein. 1992. Immunosuppression induced by attenuated Salmonella: effect of LPS responsiveness on development of suppression. Microb. Pathog. 12:267-278.
4. Al-Ramadi, B. K., J. J. Meissler, Jr., D. Huang, and T. K. Eisenstein. 1992. Immunosuppression induced by nitric oxide and its inhibition by interleukin-4. Eur. J. Immunol. 22:2249-2254.
5. Anthony, L. S. D., P. J. Morrissey, and F. E. Nano. 1992. Growth inhibition of Francisella tularensis live vaccine strain by IFN-γ-activated macrophages is mediated by reactive nitrogen intermediates derived from L-arginine metabolism. J. Immunol. 148:1829-1834.
6. Beauvais, F., L. Michel, and L. Dubertret 1995. Exogenous nitric oxide elicits chemotaxis of neutrophils in vitro. J. Cell. Physiol. 165:610-614.
7. Boockvar, K. S., D. L. Granger, R. M. Poston, M. Maybodi, M. K. Washington, J. B. Hibbs, Jr., and R. L. Karlander. 1994. Nitric oxide produced during murine listeriosis is protective. Infect. Immun. 62:1089-1100.
8. Chan, J., K. Tanaka, D. Carroll, J. Flynn, and B. R. Bloom. 1995. Effects of nitric oxide synthase inhibitors on murine infection with Mycobacterium tuberculosis. Infect. Immun. 63:736-740.
9. Chan, J., Y. Xing, R. S. Magliozzo, and B. R. Bloom. 1992. Killing of virulent Mycobacterium tuberculosis by reactive nitrogen intermediates produced by activated murine macrophages. J. Exp. Med. 175:1111-1122.
10. Chatfield, S., M. Roberts, P. Londono, I. Cropley, G. Douce, and G. Dougan. 1993. The development of oral vaccines based on live attenuated Salmonella strains. FEMS Immunol. Med. Microbiol. 7:1-8.
11. Cunningham, A., and A. Szenberg. 1968. Further improvements in the plaque technique for detecting single antibody-forming cells. Immunology 14:599-600.
12. De Groote, M. A., D. Granger, Y. Xu, G. Campbell, R. Prince, and F. C. Fang. 1995. Genetic and redox determinants of nitric oxide cytotoxicity in a Salmonella typhimurium model. Proc. Natl. Acad. Sci. USA 92:6399-6403.
13. De Groote, M. A., U. A. Ochsner, M. U. Shiloh, C. Nathan, J. M. McCord, M. C. Dinauer, S. J. Libby, A. Vazquez-Torres, Y. Xu, and F. C. Fang. 1997. Periplasmic superoxide dismutase protects Salmonella from products of phagocyte NADPH-oxidase and nitric oxide synthase. Proc. Natl. Acad. Sci. USA 94:13997-14001.
14. De Groote, M. A., T. Testerman, Y. Xu, G. Stauffer, and F. C. Fang. 1996. Homocysteine antagonism of nitric oxide-related cytostasis in Salmonella typhimurium. Science 272:414-416.
15. Denis, M. 1991. Tumor necrosis factor and granulocyte macrophage-colony stimulating factor stimulate human macrophages to restrict growth of virulent Mycobacterium avium and to kill avirulent M. avium: killing effector mechanism depends on the generation of reactive nitrogen intermediates. J. Leukoc. Biol. 49:380-387.
16. Eisenstein, T. K., N. Dalal, L. Killar, J.-C. Lee, and R. Schafer. 1988. Paradoxes of immunity and immunosuppression in Salmonella infection. Adv. Exp. Med. Biol. 239:353-366.
17. Eisenstein, T. K., L. W. Deakins, L. Killar, P. H. Saluk, and B. M. Sultzer. 1982. Dissociation of innate susceptibility to Salmonella infection and endotoxin responsiveness in C3HeB/FeJ mice and other strains in the C3H lineage. Infect. Immun. 36:696-703.
18. Eisenstein, T. K., D. Huang, J. J. Meissler, Jr., and B. K. Al-Ramadi. 1994. Macrophage nitric oxide mediates immunosuppression in infectious inflammation. Immunobiology 191:493-502.
19. Eisenstein, T. K., L. M. Killar, B. A. D. Stocker, and B. M. Sultzer. 1984 Cellular immunity induced by avirulent Salmonella in LPS-defective C3H/ HeJ mice. J. Immunol. 133:958-961.
20. Eisenstein, T. K., J. J. Meissler, Jr., S. I. Miller, and B. A. D. Stocker. 1998 Immunosuppression and nitric oxide production induced by parenteral live Salmonella vaccines do not correlate with protective capacity: a phoP::Tn10 mutant does not suppress but does protect. Vaccine 16:24-32.
21. Eisenstein, T. K., M. G. Schwacha, D. Huang, and J. J. Meissler, Jr. 1997 Attenuated Salmonella vaccines are immunosuppressive by macrophage-mediated production of nitric oxide, p. 353-359. In G. T. Keusch and M. Kawakami (ed.), Cytokines, cholera, and the gut. IOS Press, Ohmsha, Japan.
22. Eisenstein, T. K., and B. M. Sultzer. 1983. Immunity to Salmonella infection. Adv. Exp. Med. Biol. 162:261-296.
23. Evans, T. G., L. Thai, D. L. Granger, and J. B. Hibbs, Jr. 1993. Effect of in vivo inhibition of nitric oxide production in murine leishmaniasis. J. Immunol. 151:907-915.
24. Fang, F. C. 1997. Perspective series: host/pathogen interactions: mechanisms of nitric oxide-related antimicrobial activity. J. Clin. Invest. 99:2818-2825.
25. Flesch, I. E. A., and S. H. E. Kaufmann. 1991. Mechanisms involved in Mycobacterial growth inhibition by gamma interferon-activated bone marrow macrophages: role of reactive nitrogen intermediates. Infect. Immun. 59: 3213-3218.
26. Flynn, J. L., C. A. Scanga, K. E. Tanaka, and J. Chan. 1998. Effects of aminoguanidine on latent murine tuberculosis. J. Immunol. 160:1796-1803.
27. 15N) in biological fluids. Anal. Biochem. 126:131-138.
28. Green, S. J., M. S. Meltzer, J. B. Hibbs, Jr., and C. A. Nacy. 1990. Activated macrophages destroy intracellular Leishmania major amastigotes by an L-arginine-dependent killing mechanism. J. Immunol. 144:278-283.
29. Hachicha, M., P. Rathanaswami, P. H. Naccache, and S. R. McColl. 1998 Regulation of chemokine gene expression in human peripheral blood neutrophils phagocytosing microbial pathogens. J. Immunol. 160:449-454.
30. Hayashi, S., C. C. Chan, R. Gazzinelli, and F. G. Roberge. 1996. Contribution of nitric oxide to the host parasite equilibrium in toxoplasmosis. J. Immunol. 156:1476-1481.
31. - infection in gene-targeted immunodeficient mice. J. Immunol. 156:3321-3326.
32. Hoiseth, S. K., and B. A. D. Stocker. 1981. Aromatic-dependent Salmonella typhimurium are non-virulent and effective as live vaccines. Nature 291:238-239.
33. Holscher, C., G. Kohler, U. Muller, H. Mossmann, G. A. Schaub, and F. Brombacher. 1998. Defective nitric oxide effector functions lead to extreme susceptibility of Trypanosoma cruzi-infected mice deficient in gamma interferon receptor or inducible nitric oxide synthase. Infect. Immun. 66:1208-1215.
34. Huang, D., M. G. Schwacha, and T. K. Eisenstein. 1996. Attenuated Salmonella vaccine-induced suppression of murine spleen cell responses to mitogen is mediated by macrophage nitric oxide: quantitative aspects. Infect. Immun. 64:3786-3792.
35. Jiang, X., B. Leonard, R. Benson, and C. L. Baldwin. 1993. Macrophage control of Brucella abortus: role of reactive oxygen intermediates and nitric oxide. Cell. Immunol. 151:309-319.
36. Kersten-Scharton, T. M., G. Yap, J. Magram, and A. Sher. 1997. Inducible nitric oxide is essential for host control of persistent but not acute infection with the intracellular pathogen Toxoplasma gondii. J. Exp. Med. 185:1261-1273.
37. Killar, L. M., and T. K. Eisenstein. 1985. Immunity to Salmonella typhimurium infection in C3H/HeJ and C3H/HeNCrlBR mice: studies with an aromatic-dependent live S. typhimurium strain as a vaccine. Infect. Immun. 47:605-612.
38. Lee, J.-C., C. W. Gibson, and T. K. Eisenstein. 1985. Macrophage-mediated mitogenic suppression induced in mice of the C3H lineage by a vaccine strain of Salmonella typhimurium. Cell. Immunol. 91:75-91.
39. Levine, M. M., and D. M. Hone. 1991. Typhoid fever, p. 59-72 In S. J. Cryz (ed.), Vaccines and immunotherapy. Pergamon Press, New York, N.Y.
40. Liew, F. Y., Y. Li, and S. Millott. 1990. Tumor necrosis factor-α synergizes with IFN-γ in mediating killing of Leishmania major through the induction of nitric oxide. J. Immunol. 145:4306-4310.
41. Liew, F. Y., Y. Li, D. Moss, C. Parkinson, M. V. Rogers, and S. Moncada. 1991. Resistance to Leishmania major infection correlates with the induction of nitric oxide synthase in murine macrophages. Eur. J. Immunol. 21:3009-3014.
42. Liew, F. Y., S. Millot, C. Parkinson, R. M. J. Palmer, and S. Moncada. 1990. Macrophage killing of Leishmania parasite in vivo is mediated by nitric oxide from L-arginine. J. Immunol. 144:4794-4797.
43. MacMicking, J. D., C. Nathan, G. Hom, N. Chartrain, D. S. Fletcher, M. Trumbauer, K. Stevens, W. Q. Xie, K. Sokol, N. Hutchinson, H. Chen, and J. S. Mudgett. 1995. Altered responses to bacterial infection and endotoxic shock in mice lacking inducible nitric oxide synthase. Cell 81:641-650.
44. Malawista, S. E., and A. de Boisfleury Chevance. 1997. Chemotaxis by human neutrophils and their cytokineplasts treated with inhibitors of nitric oxide synthase: no suppression of orientation or tajectory. J. Leukoc. Biol. 61:58-62.
45. G-monomethyl-L-arginine. J. Immunol. 159:5063-5069.
46. Munoz-Fernandez, M. A., M. A. Fernandez, and M. Fresno. 1992. Synergism between tumor necrosis factor-α and interferon-γ on macrophage activation for the killing of intracellular Trypanosoma cruzi through a nitric oxide-dependent mechanism. Eur. J. Immunol. 22:301-307.
47. Perretti, M., C. Szabo, and C. Thiemermann. 1995. Effect of interleukin-4 and interleukin-10 on leukocyte migration and nitric oxide production in the mouse. Br. J. Pharmacol. 116:2251-2257.
48. 2 and to L-arginine-dependent system in murine macrophages. Microbiol. Immunol. 354:325-329.
49. Schafer, R., C. A. Nacy, and T. K. Eisenstein. 1988. Induction of activated macrophages in C3H/HeJ mice by avirulent Salmonella. J. Immunol. 140: 1638-1644.
50. Schmidt, H. H. H. W., T. D. Warner, M. Nakane, U. Forstermann, and F. Murad. 1992. Regulation and subcellular location of nitrogen oxide synthases in RAW264.7 macrophages. Mol. Pharmacol. 41:615-624.
51. Schwacha, M. G., and T. K. Eisenstein. 1997. Interleukin-12 is critical for induction of nitric oxide-mediated immunosuppression following vaccination of mice with attenuated Salmonella typhimurium. Infect. Immun. 65:4897-4903.
52. Shiloh, M., J. Ruan, and C. Nathan. 1997. Evaluation of bacterial survival and phagocyte function with a fluorescence-based microplate assay. Infect. Immun. 65:3193-3197.
53. Sinha, K., P. Mastroeni, J. Harrison, R. Demarco de Hormaeche, and C. E. Hormaeche. 1997. Salmonella typhimurium aroA, htrA, and aroD hatrA mutants cause progressive infections in athymic (nu/nu) BALB/c mice. Infect. Immun. 65:1566-1569.
54. Tsai, W. C., R. M. Strieter, D. A. Zisman, J. M. Wilkowski, K. A. Bucknell, G. Chen, and T. J. Standiford. 1997. Nitric oxide is required for effective innate immunity against Klebsiella pneumoniae. Infect. Immun. 65:1870-1875.
55. Umezawa, K., T. Akaike, S. Fujii, M. Suga, K. Setoguchi, A. Ozawa, and H. Maeda. 1997. Induction of nitric oxide synthesis and xanthine oxidase and their roles in the antimicrobial mechanism against Salmonella typhimurium in mice. Infect. Immun. 65:2932-2940.
56. Vincendeau, P., S. Daulouede, B. Veyret, M. L. Darde, B. Bouteille, and J. L. Lemesre. 1992. Nitric oxide-mediated cytostatic activity on Trypanosoma brucei gambiense and Trypanosoma brucei brucei. Exp. Parasitol. 75:353-360.